Testing effectiveness (Phase 2)WithdrawnNCT06646016What this trial is testingEPIC- Extracorporeal Photopheresis (ECP) for Immune-related ColitisWho this might be right forImmune-related Colitis Therakos LLC
Testing effectiveness (Phase 2)UnknownNCT00930566What this trial is testingExtracorporal Photopheresis Pilot StudyWho this might be right forHematological Malignancies Hospices Civils de Lyon 20
Not applicableStudy completedNCT00002011What this trial is testingThe Therakos UVAR Photopheresis System in the Treatment of AIDS-Related ComplexWho this might be right forHIV Infections Therakos
Testing effectiveness (Phase 2)Study completedNCT00248365What this trial is testingTheralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD)Who this might be right forGraft vs Host Disease Kiadis Pharma 20
Early research (Phase 1)WithdrawnNCT00157027What this trial is testingRHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)Who this might be right forHIV Infections Atlantic Health System
Not applicableStudy completedNCT04226521What this trial is testingExtracorporeal Photopheresis and Early Cardiac Graft VasculopathyWho this might be right forCardiac Allograft VasculopathyHeart Transplant Rejection Bosko Skoric 38
Not applicableUnknownNCT03583229What this trial is testingCoronary Artery Disease After Heart TransplantationWho this might be right forCoronary Artery Disease in Transplanted Heart (Diagnosis)Platelet Dysfunction Aarhus University Hospital 70
Testing effectiveness (Phase 2)Ended earlyNCT04446182What this trial is testingItacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHDWho this might be right forChronic Graft-versus-host-disease University of Utah 3
Testing effectiveness (Phase 2)Looking for participantsNCT06663722What this trial is testingAxatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host DiseaseWho this might be right forChronic Graft Versus Host DiseasecGVHD University of Miami 49
Testing effectiveness (Phase 2)Study completedNCT00306969What this trial is testingStudy of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-Cell Lymphoma Boston University 18
Not applicableEnded earlyNCT01324908What this trial is testingBiomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal PhotophoresisWho this might be right forGraft Versus Host Disease (GVHD) Vanderbilt-Ingram Cancer Center 85
Testing effectiveness (Phase 2)UnknownNCT03605940What this trial is testingA Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host DiseaseWho this might be right forAcute-graft-versus-host Disease Central Hospital, Nancy, France 78
Testing effectiveness (Phase 2)Ended earlyNCT00157001What this trial is testingFeasibility Study of Photopheresis Post AngioplastyWho this might be right forStable Angina PectorisUnstable Angina PectorisSilent Ischemia Atlantic Health System 120
Not applicableStudy completedNCT06899828What this trial is testingUnraveling Mechanism of Action of Extracorporeal Photopheresis in Heart and Lung Transplant PatientsWho this might be right forHeart Transplanted PatientsLung Transplanted PatientsChronic Lung Allograft Dysfunction (CLAD)+1 more Fondazione IRCCS Policlinico San Matteo di Pavia 26
Not applicableLooking for participantsNCT07434869What this trial is testingPlasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLADWho this might be right forLung Transplant Failure and RejectionCLAD, Bronchiolitis ObliteransExtracorporeal Photopheresis Brian Keller 25
Not applicableStudy completedNCT05882331What this trial is testingExtracorporeal Photopheresis as a Possible Therapeutic Approach to Adults With Severe and Critical COVID-19Who this might be right forCOVID-19 Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04986605What this trial is testingExtracorporeal Photopheresis in Early Diffuse Cutaneous Systemic SclerosisWho this might be right forDiffuse Cutaneous Systemic Sclerosis London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 15
Testing effectiveness (Phase 2)UnknownNCT06133192What this trial is testingSteroids Versus ECP and Steroids as First-line Treatment of Grade II Acute GVHDWho this might be right forGraft Vs Host Disease Central Hospital, Nancy, France 42
Post-approval studies (Phase 4)Study completedNCT00221039What this trial is testingPhotopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2AWho this might be right forCutaneous T Cell LymphomaMycosis Fungoides M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT02340676What this trial is testingA Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHDWho this might be right forChronic Graft-versus-host-disease Dana-Farber Cancer Institute 25